Actinogen Medical outlines scientific case for Xanamem in Alzheimer’s disease ahead of pivotal trial results Proactive Investors (Australia) 5d
The Small Cap Wrap: Actinogen Medical targets Alzheimer’s treatment gap; Percheron Phase II progress supports Edison’s 5.5-cent valuation Proactive Investors (Australia) 6d
Actinogen Medical targets Alzheimer’s treatment gap in projected $20BN market Proactive Investors (Australia) 6d
Actinogen Medical advances pivotal XanaMIA trial towards November readout - ICYMI Proactive Investors (US) 01:08 Sat, 01 Aug
Australian shares dip as Westpac weighs on banks ahead of RBA decision Mint 20h Australia South Pacific All sources
ASIC unveils new small business strategy Mortgage Professional 5d ASIC Australian Real Estate Australia All sources
Foxtron codevelops battery EV with Mitsubishi Motors Taipei Times 5h Mitsubishi New Zealand South Pacific All sources
The Small Cap Wrap: Elk IPO, Provaris research upgrade and more... Proactive Investors (Australia) 15h All sources
